Abstract:BACKGROUND: It was demonstrated that the cultivated human bone mesenchymal stem cells (BMSCs) presented senescent cell morphology with the passage number increased. However, it is poorly understood whether age would affect senescence process of BMSCs. OBJECTIVE: To explore the effects of age on number, proliferation, cell senescence and oxidative stress of cultivated BMSCs. DESIGN, TIME AND SETTING: The single factor design, in vitro cytology contrast experiment was performed at the Second Xiangya Hospital, Central South University between July and December 2007. MATERIALS: The bone marrow were harvested from 28 healthy volunteers, including 14 aged people, 10 male and 4 female, aged 60-73 years, with mean age of 65 years old. Fourteen young people comprise 9 male and 5 female, aged 18-28 years, with mean age of 25 years old. METHODS: Totally 2.0-3.0 mL bone marrow were extracted from volunteers from posterior superior iliac spine under aseptic condition, and then injected into anticoagulative tube containing heparin, diluted with isovolumic PBS, followed by centrifugation, next, 1×105/cm2, cells were cultured in 6-well culture plate. After 4 days of incubation, the culture solution was renewed and adherent cells were removed. The culture solution was renewed every 3 days. MAIN OUTCOME MEASURES: Cell morphology and growth status were observed by a inverted microscope, expression of surface antigen was detected by flow cytometry, the fibroblast colony-forming unit (CFU-F), senescence-associated β-galactosidase (SA-β-Gal) staining and supernatant malondialdehyde (MDA) content were compared between two groups. RESULTS: BMSCs expressed antigens of CD44 and CD105, but not CD34. There was no difference in morphology of the primary and the second passage BMSCs between two groups, however, the elder BMSCs needed more time to reach the first and second confluence than the young BMSCs (P < 0.05). CFU-F of the primary BMSCs was higher in young group (P < 0.05). Many senescent BMSCs, which were large and flat in shape and showed aquamarine in cytoplasma after SA-β-Gal staining, appeared among the fifth passage BMSCs from the elders. Most of the fifth passage BMSCs from the youths were spindle-shaped and did not show aquamarine in cytoplasma after SA-β-Gal staining. The supernatant MDA content increased in BMSCs from the elders with increase in number of passages (P < 0.05). The percentage of SA-β-Gal positive cell and supernatant MDA content in the fifth passage BMSCs were significantly higher in elder group than young group (P < 0.05). CONCLUSION: Human BMSCs number and proliferation drop with age. Furthermore, early passage BMSCs from elders present senescent cell morphology with increased oxidative stress.

Inflammatory Microenvironment Accelerates Bone Marrow Mesenchymal Stem Cell Aging

Age-related Changes in Bone Marrow Mesenchymal Stromal Cells

Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression

Mesenchymal Stem Cell Aging: Mechanisms and Influences on Skeletal and Non-Skeletal Tissues

Anti-inflammatory therapeutic biomarkers identified of human bone marrow mesenchymal stem cell therapy on aging mice by serum proteomics and peptidomics study

Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies.

Rescuing Replication and Osteogenesis of Aged Mesenchymal Stem Cells by Exposure to a Young Extracellular Matrix.

Rejuvenation of Mesenchymal Stem Cells to Ameliorate Skeletal Aging

Microenvironmental Views on Mesenchymal Stem Cell Differentiation in Aging

Effect of age on growth and senescence of human bone mesenchymal stem cells

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies

The age-related characteristics in bone microarchitecture, osteoclast distribution pattern, functional and transcriptomic alterations of BMSCs in mice

Mesenchymal stem cells alleviate aging in vitro and in vivo

Functional and Molecular Changes of Mscs in Aging

Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy

Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF-κB activity

Age-Related Effects on MSC Immunomodulation, Macrophage Polarization, Apoptosis, and Bone Regeneration Correlate with IL-38 Expression

Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice

Reduced protein intake and aging affects the sustainment of hematopoiesis by impairing bone marrow mesenchymal stem cells

Age-related BMAL1 Change Affects Mouse Bone Marrow Stromal Cell Proliferation and Osteo-Differentiation Potential.

Radiation-Induced Osteocyte Senescence Alters Bone Marrow Mesenchymal Stem Cell Differentiation Potential via Paracrine Signaling